Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial

Jyoti Mayadev, Dmitriy Zamarin, Wei Deng, Heather A. Lankes, Giulio Pesci, Hayeon Kim, Junzo P. Chino, Barbara Banbury, Ned Sherry, Elad Sharon, Sharad A. Ghamande, Catherine Ferguson, Loren Mell, Laura Holman, Cara Mathews, David O’Malley, Alexander Olawaiye, Elizabeth Hopp, Charles Leath, Larry Copeland, Robert Mannel, Roisin O’Cearbhaill, Carol Aghajanian, Russell J. Schilder

Open source

DOI: 10.1038/s41467-024-55200-2
Published: 2025-01-09
Container: Nature Communications
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-024-55200-2,
  title = {Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial},
  author = {Jyoti Mayadev and Dmitriy Zamarin and Wei Deng and Heather A. Lankes and Giulio Pesci and Hayeon Kim and Junzo P. Chino and Barbara Banbury and Ned Sherry and Elad Sharon and Sharad A. Ghamande and Catherine Ferguson and Loren Mell and Laura Holman and Cara Mathews and David O’Malley and Alexander Olawaiye and Elizabeth Hopp and Charles Leath and Larry Copeland and Robert Mannel and Roisin O’Cearbhaill and Carol Aghajanian and Russell J. Schilder},
  year = {2025},
  journal = {Nature Communications},
  doi = {10.1038/s41467-024-55200-2},
  url = {https://doi.org/10.1038/s41467-024-55200-2}
}

RIS

TY  - JOUR
TI  - Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial
AU  - Jyoti Mayadev
AU  - Dmitriy Zamarin
AU  - Wei Deng
AU  - Heather A. Lankes
AU  - Giulio Pesci
AU  - Hayeon Kim
AU  - Junzo P. Chino
AU  - Barbara Banbury
AU  - Ned Sherry
AU  - Elad Sharon
AU  - Sharad A. Ghamande
AU  - Catherine Ferguson
AU  - Loren Mell
AU  - Laura Holman
AU  - Cara Mathews
AU  - David O’Malley
AU  - Alexander Olawaiye
AU  - Elizabeth Hopp
AU  - Charles Leath
AU  - Larry Copeland
AU  - Robert Mannel
AU  - Roisin O’Cearbhaill
AU  - Carol Aghajanian
AU  - Russell J. Schilder
PY  - 2025
JO  - Nature Communications
DO  - 10.1038/s41467-024-55200-2
UR  - https://doi.org/10.1038/s41467-024-55200-2
ER  -

APA

Mayadev, J., Zamarin, D., Deng, W., Lankes, H. A., Pesci, G., Kim, H., Chino, J. P., Banbury, B., Sherry, N., Sharon, E., Ghamande, S. A., Ferguson, C., Mell, L., Holman, L., Mathews, C., O’Malley, D., Olawaiye, A., Hopp, E., Leath, C., Copeland, L., Mannel, R., O’Cearbhaill, R., Aghajanian, C., & Schilder, R. J. (2025). Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial. Nature Communications. https://doi.org/10.1038/s41467-024-55200-2

Source records

crossref · retrieved 2026-09-27T05:58:52.774Z